Cover Image
市場調查報告書

Proteome Sciences Plc : 產品平台分析

Proteome Sciences Plc - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 277784
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Proteome Sciences Plc : 產品平台分析 Proteome Sciences Plc - Product Pipeline Review - 2015
出版日期: 2015年08月12日 內容資訊: 英文 22 Pages
簡介

Proteome Sciences Plc是提供生物標記評估,等壓/同壓試劑,生物標記·服務及獨家生物標記等各種領域上個體化醫療內容的生命科學企業。

本報告提供Proteome Sciences Plc的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Proteome Sciences Plc的基本資料

  • Proteome Sciences Plc概要
  • 主要資訊
  • 企業資料

Proteome Sciences Plc :R&D概要

  • 主要的治療範圍

Proteome Sciences Plc :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Proteome Sciences Plc :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Proteome Sciences Plc :藥物簡介

  • PS-110
  • PS-278
  • Small Molecule to Inhibit CK1D for Alzheimer's Disease

Proteome Sciences Plc :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Proteome Sciences Plc :最近的開發平台趨勢

Proteome Sciences Plc :企業發表

Proteome Sciences Plc :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07499CDB

Summary

Global Markets Direct's, 'Proteome Sciences Plc - Product Pipeline Review - 2015', provides an overview of the Proteome Sciences Plc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Proteome Sciences Plc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Proteome Sciences Plc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Proteome Sciences Plc's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Proteome Sciences Plc's pipeline products

Reasons to buy

  • Evaluate Proteome Sciences Plc's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Proteome Sciences Plc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Proteome Sciences Plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Proteome Sciences Plc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Proteome Sciences Plc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Proteome Sciences Plc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
  • Proteome Sciences Plc Snapshot
    • Proteome Sciences Plc Overview
    • Key Information
    • Key Facts
  • Proteome Sciences Plc - Research and Development Overview
    • Key Therapeutic Areas
  • Proteome Sciences Plc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Proteome Sciences Plc - Pipeline Products Glance
    • Proteome Sciences Plc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Proteome Sciences Plc - Drug Profiles
    • PS-110
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PS-278
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit CK1D for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Proteome Sciences Plc - Pipeline Analysis
    • Proteome Sciences Plc - Pipeline Products by Target
    • Proteome Sciences Plc - Pipeline Products by Route of Administration
    • Proteome Sciences Plc - Pipeline Products by Molecule Type
    • Proteome Sciences Plc - Pipeline Products by Mechanism of Action
  • Proteome Sciences Plc - Recent Pipeline Updates
  • Proteome Sciences Plc - Company Statement
  • Proteome Sciences Plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Proteome Sciences Plc, Key Information
  • Proteome Sciences Plc, Key Facts
  • Proteome Sciences Plc - Pipeline by Indication, 2015
  • Proteome Sciences Plc - Pipeline by Stage of Development, 2015
  • Proteome Sciences Plc - Monotherapy Products in Pipeline, 2015
  • Proteome Sciences Plc - Preclinical, 2015
  • Proteome Sciences Plc - Pipeline by Target, 2015
  • Proteome Sciences Plc - Pipeline by Route of Administration, 2015
  • Proteome Sciences Plc - Pipeline by Molecule Type, 2015
  • Proteome Sciences Plc - Pipeline Products by Mechanism of Action, 2015
  • Proteome Sciences Plc - Recent Pipeline Updates, 2015
  • Proteome Sciences Plc, Subsidiaries
Back to Top